Joji Nagasaki

5PUBLICATIONS
66CO-AUTHORS
Haematological tumoursCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 18, 2026
Incidence of B-cell Malignancies in Patients with Lung Cancer Receiving PD-1 Blockade Therapy.

|Jul 01, 2025
Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity.

Yuto Naoi, Yumi Inukai, Tomoka Izumikawa

|Jan 13, 2025
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy.

Toshifumi Ninomiya, Naoya Kemmotsu, Fumiaki Mukohara

|Apr 18, 2024
CD106 in Tumor-Specific Exhausted CD8+ T Cells Mediates Immunosuppression by Inhibiting TCR Signaling.

Yuto Naoi, Takao Morinaga, Joji Nagasaki

|Apr 16, 2023
High Expression of MHC Class I Overcomes Cancer Immunotherapy Resistance Due to IFNγ Signaling Pathway Defects.

Katsushige Kawase, Shusuke Kawashima, Joji Nagasaki

Pageof 1

Frequent Collaborators

5 joint publications

Yosuke Togashi

4 joint publications

Youki Ueda

3 joint publications

Takamasa Ishino

2 joint publications

Katsushige Kawase